NT5E and cancer: Evidence has shown increased CD73 protein expression in cancer cells developing resistance to various therapies, e.g., chemotherapy [55,102], radiotherapy [56,103], and targeted therapy [104,105], as well as immunotherapy [71,96], suggesting that this enzyme is involved in treatment resistance.